Alkermes (ALKS)

Executive Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. More Details


Trading at 31.6% below our estimate of its fair value

Earnings have grown 11.3% per year over the past 5 years

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Snowflake Analysis

Excellent balance sheet and fair value.

Similar Companies

Search for a company to compare.